Switch theme
Sign up to access all valuation multiples
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
2022
10
Last FY Revenue $0.4M
Last FY EBITDA -$0.6M
$80.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Pheton Holdings achieved revenue of $0.4M and an EBITDA of -$0.6M.
Pheton Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pheton Holdings valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.4M | XXX | XXX | XXX |
| Gross Margin | XXX | 85% | XXX | XXX | XXX |
| EBITDA | XXX | -$0.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -132% | XXX | XXX | XXX |
| EBIT | XXX | -$0.7M | XXX | XXX | XXX |
| EBIT Margin | XXX | -148% | XXX | XXX | XXX |
| Net Profit | XXX | -$0.7M | XXX | XXX | XXX |
| Net Margin | XXX | -147% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Pheton Holdings's stock price is $6.
Pheton Holdings has current market cap of $86.8M, and EV of $80.9M.
See Pheton Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $80.9M | $86.8M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Pheton Holdings has market cap of $86.8M and EV of $80.9M.
Pheton Holdings's trades at 180.4x EV/Revenue multiple, and -137.2x EV/EBITDA.
Equity research analysts estimate Pheton Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pheton Holdings's P/E ratio is not available.
See valuation multiples for Pheton Holdings and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $86.8M | XXX | $86.8M | XXX | XXX | XXX |
| EV (current) | $80.9M | XXX | $80.9M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 180.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -137.2x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -122.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -131.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -104.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPheton Holdings's revenue per employee in the last FY averaged $45K, while opex per employee averaged $0.1M for the same period.
Pheton Holdings's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pheton Holdings's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Pheton Holdings and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -132% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $45K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 69% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 21% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 233% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pheton Holdings acquired XXX companies to date.
Last acquisition by Pheton Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Pheton Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Pheton Holdings founded? | Pheton Holdings was founded in 2022. |
| Where is Pheton Holdings headquartered? | Pheton Holdings is headquartered in United States of America. |
| How many employees does Pheton Holdings have? | As of today, Pheton Holdings has 10 employees. |
| Who is the CEO of Pheton Holdings? | Pheton Holdings's CEO is Mr. Jianfei Zhang. |
| Is Pheton Holdings publicy listed? | Yes, Pheton Holdings is a public company listed on NAS. |
| What is the stock symbol of Pheton Holdings? | Pheton Holdings trades under PTHL ticker. |
| When did Pheton Holdings go public? | Pheton Holdings went public in 2024. |
| Who are competitors of Pheton Holdings? | Similar companies to Pheton Holdings include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Pheton Holdings? | Pheton Holdings's current market cap is $86.8M |
| Is Pheton Holdings profitable? | Yes, Pheton Holdings is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
